<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00522782</url>
  </required_header>
  <id_info>
    <org_study_id>IRUSBUPR-0062</org_study_id>
    <nct_id>NCT00522782</nct_id>
  </id_info>
  <brief_title>Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children</brief_title>
  <official_title>Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AAADRS Clinical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AAADRS Clinical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the improvement in airway inflammation in children with asthma non-invasively with
      exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg
      daily.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparisons will be made before and after 2 week therapy of nebulized budesonide in children
      not on prior anti-inflammatory medications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exhaled breath nitric oxide pre- to post treatment</measure>
    <time_frame>two weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spirometry with peak flow measurements and daily diary scores</measure>
    <time_frame>two weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nebulized budesonide</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nebulized Budesonide</intervention_name>
    <description>Pulmicort Respules 0.5mg/2cc</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Pulmicort Respules 0.5mg/2ml nebulized</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nitric Oxide Analyzer</intervention_name>
    <description>Niox NO analyzer</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Niox NO analyzer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma diagnosis previously for 6 months

          -  Past asthma medication without change for previous 6 months

          -  Increased NO levels and ability to perform maneuver

          -  ICF signed by parents

        Exclusion Criteria:

          -  Systemic steroids in past 60 days,inhaled/nebulized steroids in past 4 weeks

          -  Hospitalization within 3 months

          -  Upper or lower airways active infection or cigarette smoke direct exposure

          -  Use of other asthma medications other than bronchodilators one month prior and during
             the trial

          -  Noncompliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel J Lanz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AAADRS Clinical Research Center</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2007</study_first_submitted>
  <study_first_submitted_qc>August 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2007</study_first_posted>
  <last_update_submitted>January 22, 2009</last_update_submitted>
  <last_update_submitted_qc>January 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>Miguel Lanz, MD</name_title>
    <organization>AAADRS</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 19, 2012</submitted>
    <returned>February 22, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

